27-Hydroxycholesterol: a potential endogenous regulator of estrogen receptor signaling

Trends in Pharmacological Sciences

Volumn 29, Issue 10, 2008, Pages 510-514

  DuSell, Carolyn D ^a   McDonnell, Donald P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

26 HYDROXYCHOLESTEROL; CHOLESTANETRIOL 26 MONOOXYGENASE; CHOLESTEROL; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ESTROGEN RECEPTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INDUCIBLE NITRIC OXIDE SYNTHASE; LIVER X RECEPTOR; SELECTIVE ESTROGEN RECEPTOR MODULATOR; TAMOXIFEN;

ARTICLE; CHOLESTEROL METABOLISM; ESTROGEN METABOLISM; ESTROGEN RELEASE; HORMONAL REGULATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; BREAST NEOPLASMS; CARDIOVASCULAR DISEASES; CHOLESTEROL; DISEASE MODELS, ANIMAL; HUMANS; HYDROXYCHOLESTEROLS; RECEPTORS, ESTROGEN; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 52949115639     PISSN: 01656147     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tips.2008.07.003     Document Type: Article

References (39)

1. Chahal H.S., and Drake W.M. The endocrine system and ageing. J. Pathol. 211 (2007) 173-180
2. Vagenakis A.G. Endocrine aspects of menopause. Clin. Rheumatol. 8 Suppl. 2 (1989) 48-51
3. Green S., et al. Human oestrogen receptor cDNA: sequence, expression and homology to v-erb-A. Nature 320 (1986) 134-139
4. Kuiper G.G., et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138 (1997) 863-870
5. Kuiper G.G., et al. Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. Sci. U. S. A. 93 (1996) 5925-5930
6. Couse J.F., et al. Tissue distribution and quantitative analysis of estrogen receptor-α (ERα) and estrogen receptor-β (ERβ) messenger ribonucleic acid in the wild-type and ERα-knockout mouse. Endocrinology 138 (1997) 4613-4621
7. Bjornstrom L., and Sjoberg M. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol. Endocrinol. 19 (2005) 833-842
8. Smith C.L., and O'Malley B.W. Coregulator function: a key to understanding tissue specificity of selective receptor modulators. Endocr. Rev. 25 (2004) 45-71
9. Cheskis B.J., et al. Signaling by estrogens. J. Cell. Physiol. 213 (2007) 610-617
10. DuSell C.D., et al. 27-Hydroxycholesterol is an endogenous selective estrogen receptor modulator. Mol. Endocrinol. 22 (2008) 65-77
11. Umetani M., et al. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Nat. Med. 13 (2007) 1185-1192
12. Javitt N.B. 25R,26-Hydroxycholesterol revisited: synthesis, metabolism, and biologic roles. J. Lipid Res. 43 (2002) 665-670
13. Hansson M., et al. Marked induction of sterol 27-hydroxylase activity and mRNA levels during differentiation of human cultured monocytes into macrophages. Biochim. Biophys. Acta 1593 (2003) 283-289
14. Babiker A., et al. Elimination of cholesterol in macrophages and endothelial cells by the sterol 27-hydroxylase mechanism. Comparison with high density lipoprotein-mediated reverse cholesterol transport. J. Biol. Chem. 272 (1997) 26253-26261
15. Bjorkhem I., and Leitersdorf E. Sterol 27-hydroxylase deficiency: a rare cause of xanthomas in normocholesterolemic humans. Trends Endocrinol. Metab. 11 (2000) 180-183
16. Bjorkhem I. Do oxysterols control cholesterol homeostasis?. J. Clin. Invest. 110 (2002) 725-730
17. Meir K., et al. Human sterol 27-hydroxylase (CYP27) overexpressor transgenic mouse model. Evidence against 27-hydroxycholesterol as a critical regulator of cholesterol homeostasis. J. Biol. Chem. 277 (2002) 34036-34041
18. Brown A.J., and Jessup W. Oxysterols and atherosclerosis. Atherosclerosis 142 (1999) 1-28
19. Dzeletovic S., et al. Determination of cholesterol oxidation products in human plasma by isotope dilution-mass spectrometry. Anal. Biochem. 225 (1995) 73-80
20. Li-Hawkins J., et al. Disruption of the oxysterol 7α-hydroxylase gene in mice. J. Biol. Chem. 275 (2000) 16536-16542
21. Chambliss K.L., and Shaul P.W. Estrogen modulation of endothelial nitric oxide synthase. Endocr. Rev. 23 (2002) 665-686
22. Zhu Y., et al. Abnormal vascular function and hypertension in mice deficient in estrogen receptor β. Science 295 (2002) 505-508
23. Christopherson K.S., and Bredt D.S. Nitric oxide in excitable tissues: physiological roles and disease. J. Clin. Invest. 100 (1997) 2424-2429
24. Grodstein F., et al. Understanding the divergent data on postmenopausal hormone therapy. N. Engl. J. Med. 348 (2003) 645-650
25. Chen S., et al. New experimental models for aromatase inhibitor resistance. J. Steroid Biochem. Mol. Biol. 106 (2007) 8-15
26. Chen J.J., et al. Tumor-associated macrophages: the double-edged sword in cancer progression. J. Clin. Oncol. 23 (2005) 953-964
27. Tang R., et al. M-CSF (monocyte colony stimulating factor) and M-CSF receptor expression by breast tumour cells: M-CSF mediated recruitment of tumour infiltrating monocytes?. J. Cell. Biochem. 50 (1992) 350-356
28. Zhu P., et al. Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway. Cell 124 (2006) 615-629
29. Steele R.J., et al. A high macrophage content in human breast cancer is not associated with favourable prognostic factors. Br. J. Surg. 71 (1984) 456-458
30. Love R.R., et al. Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer. N. Engl. J. Med. 326 (1992) 852-856
31. Sverrisdottir A., et al. Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy. J. Clin. Oncol. 22 (2004) 3694-3699
32. Castagnetta L., et al. A role for sex steroids in autoimmune diseases: a working hypothesis and supporting data. Ann. N. Y. Acad. Sci. 966 (2002) 193-203
33. Jacobson D.L., et al. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin. Immunol. Immunopathol. 84 (1997) 223-243
34. Schwendimann R.N., and Alekseeva N. Gender issues in multiple sclerosis. Int. Rev. Neurobiol. 79 (2007) 377-392
35. Simard J.F., and Costenbader K.H. What can epidemiology tell us about systemic lupus erythematosus?. Int. J. Clin. Pract. 61 (2007) 1170-1180
36. Theis K.A., et al. Arthritis burden and impact are greater among U.S. women than men: intervention opportunities. J. Womens Health (Larchmt) 16 (2007) 441-453
37. Weber M.S., et al. Spotlight on statins. Int. MS J. 14 (2007) 93-97
38. Setchell K.D., et al. Identification of a new inborn error in bile acid synthesis: mutation of the oxysterol 7α-hydroxylase gene causes severe neonatal liver disease. J. Clin. Invest. 102 (1998) 1690-1703
39. McDonnell D.P. Selective Estrogen Receptor Modulators. In: Henry H.L., and Norman A.W. (Eds). Encyclopedia of Hormones Vol. 1 (2003), Elsevier 335-340